Inferred relatedness and heritability in malaria parasites.
Malaria parasites vary in phenotypic traits of biomedical or biological interest such as growth rate, virulence, sex ratio and drug resistance, and there is considerable interest in identifying the genes that underlie this variation. An important first step is to determine trait heritability (H(2)). We evaluate two approaches to measuring H(2) in natural parasite populations using relatedness inferred from genetic marker data. We collected single-clone Plasmodium falciparum infections from 185 patients from the Thailand-Burma border, monitored parasite clearance following treatment with artemisinin combination therapy (ACT), measured resistance to six antimalarial drugs and genotyped parasites using 335 microsatellites. We found strong relatedness structure. There were 27 groups of two to eight clonally identical (CI) parasites, and 74 per cent of parasites showed significant relatedness to one or more other parasites. Initially, we used matrices of allele sharing and variance components (VC) methods to estimate H(2). Inhibitory concentrations (IC(50)) for six drugs showed significant H(2) (0.24 to 0.79, p = 0.06 to 2.85 x 10(-9)), demonstrating that this study design has adequate power. However, a phenotype of current interest--parasite clearance following ACT--showed no detectable heritability (H(2) = 0-0.09, ns) in this population. The existence of CI parasites allows the use of a simple ANOVA approach for quantifying H(2), analogous to that used in human twin studies. This gave similar results to the VC method and requires considerably less genotyping information. We conclude (i) that H(2) can be effectively measured in malaria parasite populations using minimal genotype data, allowing rational design of genome-wide association studies; and (ii) while drug response (IC(50)) shows significant H(2), parasite clearance following ACT was not heritable in the population studied.
Anderson
Tim J C
TJ
Southwest Foundation for Biomedical Research, San Antonio, TX, USA. tanderso@sfbrgenetics.org
Williams
Jeff T
JT
Nair
Shalini
S
Sudimack
Daniel
D
Barends
Marion
M
Jaidee
Anchalee
A
Price
Ric N
RN
Nosten
François
F
D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D037621:Artemisinins / Q000494:pharmacology* / Q000627:therapeutic use; D004351:Drug Resistance; D014644:Genetic Variation; D006801:Humans; D020128:Inhibitory Concentration 50; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000469:parasitology; D010641:Phenotype; D010802:Phylogeny; D010963:Plasmodium falciparum / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification
D000962:Antimalarials; D037621:Artemisinins; C031327:artemisinin
J Hered. 2001 Sep-Oct;92(5):421-6
11773250
Philos Trans R Soc Lond B Biol Sci. 2004 Jun 29;359(1446):965-86
15306410
Mol Microbiol. 2004 May;52(4):985-97
15130119
Mol Ecol. 1996 Jun;5(3):393-401
8688959
Nat Rev Genet. 2007 Jul;8(7):497-506
17572690
Infect Genet Evol. 2002 Jul;1(4):287-96
12798007
Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17388-93
16301534
PLoS One. 2009;4(2):e4551
19234601
Evolution. 1996 Jun;50(3):1062-1073
28565279
Mol Biochem Parasitol. 1992 Apr;51(2):313-20
1349423
J Infect Dis. 2010 May 1;201(9):1326-30
20350192
Mol Ecol. 2000 Sep;9(9):1195-204
10972759
Antimicrob Agents Chemother. 1979 Dec;16(6):710-8
394674
Science. 1995 Sep 22;269(5231):1709-11
7569897
J Hered. 2008 Mar-Apr;99(2):94-104
18209112
Curr Drug Targets Infect Disord. 2004 Mar;4(1):1-10
15032630
Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):537-44
11132385
Int J Parasitol. 2010 Jan;40(1):109-21
19765590
Heredity (Edinb). 2000 Apr;84 ( Pt 4):427-36
10849066
Mol Cell. 2000 Oct;6(4):861-71
11090624
Mol Ecol. 2006 May;15(6):1657-67
16629818
Parasitology. 1994 Nov;109 ( Pt 4):413-21
7800409
Adv Genet. 2001;42:151-81
11037320
Br J Haematol. 2008 May;141(3):276-86
18410566
Genetics. 2009 Jul;182(3):845-50
19416939
Ann Hum Genet. 1999 Nov;63(Pt 6):545-63
11246457
Bone. 2010 Mar;46(3):835-40
19900599
Mol Biol Evol. 2000 Oct;17(10):1467-82
11018154
Genetics. 2004 Aug;167(4):1529-36
15342495
Antimicrob Agents Chemother. 2005 Jun;49(6):2180-8
15917511
N Engl J Med. 2009 Jul 30;361(5):455-67
19641202
Int J Parasitol. 2007 Dec;37(14):1599-607
17585919
Am J Trop Med Hyg. 2009 Dec;81(6):987-93
19996426
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):698-703
10639142
Science. 2008 Apr 18;320(5874):330-4
18420924
Trends Parasitol. 2001 Nov;17(11):525-31
11872397
Parasitology. 1992 Jun;104 ( Pt 3):387-95
1641238
Nat Genet. 2007 Oct;39(10):1208-16
17873875
Trans R Soc Trop Med Hyg. 1991 Jul-Aug;85(4):454-6
1755049
Trends Parasitol. 2008 Dec;24(12):537-44
18938106
Biometrics. 1974 Dec;30(4):667-80
4429760
Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):256-62
9231189
Genetics. 2006 Aug;173(4):2091-101
16783017